Search results
Added:
1 year ago
A new policy statement released by HRS underscores the importance of continual training and education for electrophysiologists performing catheter ablation of atrial fibrillation (AF).In this short interview, Dr Kenneth Ellenbogen (VCU School of Medicine, US) discusses the key recommendations within this policy statement to ensure a strong electrophysiology base and skillset to achieve the best…
View more
Added:
2 years ago
In this episode of the Radcliffe Podcast, we are joined by Dr Raymond Pranata, Dr Mohammad Iqbal and Dr Giky Karwiky (Hasan Sadikin General Hospital, Bandung, Indonesia) as they discuss their recently published systematic review and meta-analysis of very-high-power short-duration ablation as compared to conventional ablation for the treatment of pulmonary vein isolation in atrial fibrillation.13…
View more
AHA 25: The OCEAN Trial
Added:
3 months ago
Video
Added:
1 year ago
ACC.24 — We are joined by Dr Kengo Kusano (National Cerebral and Cardiovascular Center, JP) to discuss the findings from the Embo-Abl Study.Embo-Abl is a multicenter prospective randomized study which aims to compare the incidence of periprocedural cerebral embolisms caused by catheter ablation of atrial fibrillation (AF) between cryoballoon and radiofrequency ablation. 230 patients with AF from…
View more
Added:
2 years ago
ESC 2023 — We are joined onsite by Prof Christian Sohns and Prof Philipp Sommer (Heart and Diabetes Centre, Bad Oyenhausen, DE) to discuss the findings from the CASTLE-HTx trial (NCT04649801).
CASTLE-HTx (Heart and Diabetes Center North-Rhine Westfalia) aimed to determine if atrial fibrillation ablation has beneficial effects on mortality in patients with end-stage heart failure, who are…
View more
VHPSD versus Conventional Catheter Ablation in AF
Added:
2 years ago
Podcast Episode
Added:
1 year ago
EHRA 24 - We interview Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, US) on a first-in-human clinical trial of a novel conformable "single-shot" pulsed field ablation (PFA) catheter for pulmonary vein isolation (PVI).This single arm trial aimed to assess the safety and efficacy of PVI using an 8Fr PFA catheter (SpherePVI, Affera Inc) in 30 patients across three centers.Interview…
View more
Added:
10 months ago
EHRA 2025 - Positive safety results of the Affera mapping and ablation system for the treatment of ventricular arrhythmias (VA) show a 6% rate of major complication.Dr Frédéric Sacher (IHU Liryc, Bordeaux, FR) joins us on-site at EHRA Congress 2025 to discuss safety results from the European Affera Ventricular Arrhythmia Ablation Registry, investigating VA ablation with the Affera Sphere-9…
View more
Added:
16 hours ago
Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, NY, US) joins us to discuss evolving strategies for stroke management following atrial fibrillation ablation, addressing the critical question of when anticoagulation can be safely discontinued after successful ablation.Interview Questions:There's been a lot of talk about optimal anticoagulation – what's the headline? In which…
View more
Added:
1 year ago
EHRA 24 - Investigator, Dr Boris Schmidt (Cardioangiologisches Centrum Bethanien, DE) is interviewed on ablation strategies for repeat procedures in patients with recurrent atrial fibrillation (AF).The ASTRO trial is a multi-centre prospective randomized study that enrolled 256 patients with drug-refractory AF despite previous AF ablation. The trial showed no statistically significant differences…
View more